Back Bay in STAT: Microbiome Drug Development: A Rapidly Evolving Field
New White Paper: The Microbiome and Immuno-Oncology
Back Bay in STAT: Antibiotic Breakthroughs
Back Bay Report on Neoantigen-Based Cancer Immunotherapy
Blog, Jonathan Gertler Posts, Michelle Hoffmann Posts, Peter Bak Posts, WhitepapersBack Bay Life Science AdvisorsASCO, Cancer, CART-T, immuno-oncology, Neoantigens, Oncology, T Cell, White Paper
BioPharma Puts Skin in Atopic Dermatitis Game: Strategy/Transaction Insights
